Getein HCG+β Fast Test Kit is used as an aid in pregnancy test.
Intended Use
The HCG+β Fast Test Kit (Immunofluorescence Assay) is intended for in vitro quantitative determination of human chorionic gonadotropin (HCG) in human serum or plasma samples.
About HCG+β
Human chorionic gonadotropin (HCG) is a glycoprotein hormone produced by the placenta, a component of the fertilized egg, after conception. The biologically active hormone (intact HCG) is composed of noncovalently linked α and β subunits. The alpha subunit is similar to other hormones such as luteinizing hormone (LH), follicle-stimulating hormone (FSH), and thyroid-stimulating hormone (TSH). The beta subunit, however, is unique to HCG and confers its biological and immunological specificity. During a normal pregnancy, HCG levels can be detected soon after conception, doubling approximately every 72 hours and reaching a peak in the first 8-11 weeks of pregnancy.
Contents
For Getein 1100/Getein 1180
Package specifications: 25 tests/box, 10 tests/box
Getein HCG+β test card in a sealed pouch with desiccant
Disposable pipette
Sample diluent
User manual: 1 piece/box
SD card: 1 piece/box
For Getein 1600
Package specifications: 2×24 tests/kit, 2×48 tests/kit
Sealed cartridge with 24/48 Getein HCG+β test cards
User manual: 1 piece/box
Materials required for Getein 1600:
- Sample diluent: 1 bottle/box
- Box with pipette tips: 96 tips/box
- Mixing plate: 1 piece/box
Note: Do not mix or interchange different batches of kits.
Specifications
Test Item:
HCG+β
Sample:
Serum, Plasma
Method:
Immunofluorescence Assay
Storage Condition:
4-30℃
Detection Range:
5.0~100000.0 mIU/mL
Test Time:
10 min
Cut-off Value:
Refer to User Manual
Shelf Life:
24 months
Applicable Devices
- Getein 1100 Immunofluorescence Quantitative Analyzer
- Getein 1180 Immunofluorescence Quantitative Analyzer
- Getein 1600 Immunofluorescence Quantitative Analyzer
Clinical Applications
- HCG measurement in blood or urine can be used as an aid in pregnancy testing.
- Elevated HCG levels during pregnancy may indicate chorionic carcinoma, hydatidiform mole, or multiple pregnancy.
- HCG+β measurements, when used with other parameters during the second trimester of pregnancy, can help assess the risk of trisomy 21 (Down syndrome).
